Bestall, S. (2017). Diabetic neuropathy: A mechanism of TRPV1 sensitisation and the treatment with Vascular Endothelial Growth Factor-A165b (VEGF-A165b).
Chicago Style (17th ed.) CitationBestall, Samuel. Diabetic Neuropathy: A Mechanism of TRPV1 Sensitisation and the Treatment with Vascular Endothelial Growth Factor-A165b (VEGF-A165b). 2017.
MLA (9th ed.) CitationBestall, Samuel. Diabetic Neuropathy: A Mechanism of TRPV1 Sensitisation and the Treatment with Vascular Endothelial Growth Factor-A165b (VEGF-A165b). 2017.
Warning: These citations may not always be 100% accurate.